Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
SRRK Scholar Rock
- 41.980
- +0.330+0.79%
Close Dec 13 16:00 ET
- 41.980
- 0.0000.00%
Post 20:01 ET
3.93BMarket Cap-17.79P/E (TTM)
42.590High40.950Low751.97KVolume41.360Open41.650Pre Close31.64MTurnover1.06%Turnover RatioLossP/E (Static)93.61MShares46.18552wk High49.62P/B2.97BFloat Cap6.76052wk Low--Dividend TTM70.80MShs Float70.000Historical High--Div YieldTTM3.94%Amplitude4.325Historical Low42.081Avg Price1Lot Size
About Scholar Rock Company
Scholar Rock Holding Corp. is a biopharmaceutical company. It engages in the business of discovering, developing, and delivering innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.
Company Profile
SymbolSRRK
Company NameScholar Rock
Listing DateMay 24, 2018
Issue Price14.00
Founded2012
CEODr. Jay T. Backstrom, M.D.,M.P.H.
MarketNASDAQ
Employees150
Fiscal Year Ends12-31
Address301 Binney Street,3rd floor
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-857-259-3860
Websitehttp://www.scholarrock.com
Company Executives
- Name
- Position
- Salary
- Dr. Jay T. Backstrom, M.D.,M.P.H.
- Director, President and Chief Executive Officer
- 4.11M
- Caryn Parlavecchio
- Chief Human Resources Officer
- --
- Edward H. Myles
- Chief Operating Officer, Chief Financial Officer and Principal Accounting Officer
- 2.01M
- Dr. Jing L. Marantz, M.D.,PhD
- Chief Medical Officer
- --
- Mohammed Qatanani
- Chief Scientific Officer
- --
- Tracey Sacco
- Chief Commercial Officer
- 2.28M
- David L. Hallal
- Chairman of the Board
- 416.70K
- Katie Peng
- Independent Director
- --
- Kristina M. Burow
- Independent Director
- 300.34K
- Dr. Srinivas Akkaraju, M.D.,PhD
- Independent Director
- 291.23K
- Michael Gilman, PhD
- Independent Director
- 299.20K
- Richard H. Brudnick
- Independent Director
- 367.96K
- Dr. Jeffrey S. Flier, M.D.
- Independent Director
- 305.70K
- Amir H. Nashat, PhD
- Independent Director
- 295.70K
- Dr. Akshay K. Vaishnaw, M.D.,PhD
- Independent Director
- 298.20K
- Joshua Reed
- Independent Director
- 305.70K
- Junlin Ho
- General Counsel and Corporate Secretary
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.